The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

White Papers
A detailed example of a new Master of Health Administration (MHA) program with a medical logistics concentration.
AHRMM What's New
Supply chain teams across the U.S. continue to face supply shortages.
White Papers
Learn how Baptist Health forged its traditional AP cost center into a cost savings driver.
On-Demand Educational Webinars
During this webinar you will take a look at the drivers of burnout and share organizational steps for addressing well-being in your organization.
On-Demand Educational Webinars
Learn what is driving the Great Resignation and how this is affecting health care.
On-Demand Educational Webinars
A panel of provider thought leaders as discusses the ISO 80369-3 (ENFit) small bore connector conversion successes, lessons learned and…